Brookstone Capital Management Boosts Stake in Cardinal Health, Inc. $CAH

Brookstone Capital Management increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 59.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,691 shares of the company’s stock after purchasing an additional 5,107 shares during the quarter. Brookstone Capital Management’s holdings in Cardinal Health were worth $2,893,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the stock. Aventura Private Wealth LLC purchased a new stake in Cardinal Health during the 4th quarter valued at $25,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Cardinal Health in the fourth quarter worth about $26,000. Bank of Jackson Hole Trust bought a new position in shares of Cardinal Health during the 4th quarter valued at approximately $27,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Finally, Palladiem LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth about $28,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $233.61 on Thursday. The stock has a market capitalization of $54.71 billion, a P/E ratio of 35.72, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. The business has a fifty day moving average price of $205.15 and a 200 day moving average price of $209.86. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $235.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analyst Ratings Changes

CAH has been the topic of several research analyst reports. Wells Fargo & Company decreased their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Evercore lowered their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. TD Cowen increased their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Finally, William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.